Intranasal cerium oxide nanoparticles improves locomotor activity and reduces oxidative stress and neuroinflammation in haloperidol-induced parkinsonism in rats.

Front Pharmacol · 2023 · PMC10267740 · PMID 37324485

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

The results of open field and pole test showed highly significant ( p < 0.001) improvement in locomotor activity of rats treated with intranasal CONPs compared to untreated rats.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.